Can a simple breath test catch flu in High-HIV regions?
NCT ID NCT07030075
First seen Aug 05, 2026 · Last updated Aug 06, 2026 · Updated 1 time
Summary
This study in Lusaka, Zambia, aims to measure how common influenza, RSV, and COVID-19 are among adults with flu-like symptoms, comparing those with and without HIV. Researchers will follow participants for two weeks to track symptom progression and outcomes. They will also test whether a breath-based sampling method can accurately detect these viruses compared to standard nasal swabs, and ask participants about their experience with each method.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Exhaled breath aerosol sampling (a non-invasive diagnostic method)
- What this could lead to
- If successful, this could improve flu diagnosis in high-HIV settings and support faster, more acceptable testing for respiratory infections.
- What could go wrong
- This is an observational study, so it won't test a treatment. The breath sampling method may not be as accurate as standard swabs, and results may not apply beyond this specific population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chawama 1st level Hospital
RECRUITINGLusaka, Lusaka Province, 10101, Zambia
-
Kanyama 1st Level Hospital
RECRUITINGLusaka, Lusaka Province, 10101, Zambia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?